| |
| |
|
| Insider
Information: |
Mckinnell Henry A |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
3,072,534 |
|
|
Indirect Shares
|
253,582 |
|
|
| Direct
Value |
$108,322,857 |
|
|
|
Indirect Value
|
$7,506,027 |
|
|
| Total
Shares |
3,326,116 |
|
|
| Total
Value |
$115,828,884 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Moodys Corp |
MCO |
Director |
2021-03-18 |
89,488 |
2003-09-25 |
0 |
Premium* |
|
|
Pfizer Inc |
PFE |
Director |
2007-02-28 |
2,134,851 |
2007-02-28 |
253,582 |
Premium* |
|
|
Exxon Mobil Corp |
XOM |
Director |
2007-01-03 |
36,400 |
2004-05-26 |
0 |
Premium* |
|
|
Angiotech Pharmaceuticals Inc(USA) |
ANPIQ |
Director |
2008-05-12 |
50,000 |
|
0 |
Premium* |
|
|
Optimer Pharmaceuticals Inc |
OPTR |
CEO and Chairman of th... |
2013-10-24 |
0 |
|
0 |
Premium* |
|
|
Viewray, Inc. |
VRAY |
Director |
2019-01-02 |
689,046 |
2016-08-22 |
0 |
Premium* |
|
|
Chemocentryx, Inc. |
CCXI |
Director |
2022-05-20 |
72,749 |
2016-11-03 |
0 |
Premium* |
|
|
Federal Street Acquisition Corp |
FSAC |
Director |
2019-01-04 |
0 |
2019-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MCO |
Moodys Corp |
Director |
– • – |
2018-06-11 |
4 |
A |
$178.50 |
$22,313 |
D/D |
125 |
85,076 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2018-09-10 |
4 |
A |
$177.46 |
$22,537 |
D/D |
127 |
85,203 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2018-12-12 |
4 |
A |
$149.45 |
$22,866 |
D/D |
153 |
85,356 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2019-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,440 |
86,796 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2019-03-18 |
4 |
A |
$177.11 |
$25,327 |
D/D |
143 |
86,955 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2019-06-10 |
4 |
A |
$191.88 |
$26,557 |
D/D |
138 |
87,097 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2019-09-10 |
4 |
A |
$211.69 |
$25,526 |
D/D |
121 |
87,217 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2019-12-12 |
4 |
A |
$233.98 |
$26,264 |
D/D |
112 |
87,330 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2020-02-20 |
4 |
A |
$280.42 |
$250,135 |
D/D |
892 |
88,222 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2020-03-18 |
4 |
A |
$167.41 |
$27,240 |
D/D |
162 |
88,383 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2020-06-10 |
4 |
A |
$274.99 |
$30,272 |
D/D |
110 |
88,497 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2020-09-10 |
4 |
A |
$286.39 |
$30,077 |
D/D |
105 |
88,602 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2020-12-14 |
4 |
A |
$277.55 |
$30,702 |
D/D |
110 |
88,712 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2021-02-22 |
4 |
A |
$276.84 |
$179,946 |
D/D |
650 |
89,362 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2021-03-18 |
4 |
A |
$287.23 |
$36,105 |
D/D |
126 |
89,488 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2011-01-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
15,000 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
25,000 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2013-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
35,000 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
CEO and Chairman of the Board |
• • – |
2013-10-24 |
4 |
D |
$10.75 |
$268,750 |
D/D |
(25,000) |
0 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
CEO and Chairman of the Board |
• • – |
2013-10-24 |
4 |
|
$10.75 |
$107,500 |
D/D |
10,000 |
25,000 |
0 |
- |
|
| PFE |
Pfizer Inc |
Chairman and CEO |
• • – |
2003-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,250 |
1,097,198 |
|
- |
|
| PFE |
Pfizer Inc |
Chairman and CEO |
• • – |
2004-02-25 |
4 |
D |
$37.20 |
$584,970 |
D/D |
(15,725) |
1,149,087 |
|
- |
|
| PFE |
Pfizer Inc |
Chairman and CEO |
• • – |
2004-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
75,060 |
1,224,147 |
|
- |
|
| PFE |
Pfizer Inc |
Chairman and CEO |
• • – |
2004-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
125,100 |
1,353,948 |
|
- |
|
148 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
